Jauhar S, Johnstone M, McKenna PJ, Schizophrenia. Lancet. 2022;399(10323):473–86.
Article CAS PubMed Google Scholar
McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia—An overview. JAMA Psychiatry. 2020;77(2):201–10.
Blum LH, Vakhrusheva J, Saperstein A, Khan S, Chang RW, Hansen MC, et al. Depressed mood in individuals with schizophrenia: a comparison of retrospective and real-time measures. Psychiatry Res. 2015;227(2):318–23.
Article PubMed PubMed Central Google Scholar
Lise Docx MS, Sabbe B, Fransen MDPDE, Bervoets MSPDC, Hulstijn MDW, Maarten MSPD, Van Den Bossche JA. Longitudinal evaluation of the Psychomotor Syndrome in Schizophrenia. J Neuropsychiatry Clin Neurosci. 2014;26(4):359–68.
Marwaha S, Johnson S, Bebbington P, Stafford M, Angermeyer MC, Brugha T, et al. Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. Br J Psychiatry. 2007;191(1):30–7.
Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373(9657):31–41.
Article CAS PubMed Google Scholar
Lieberman JA, Small SA, Girgis RR. Early detection and preventive intervention in Schizophrenia: from Fantasy to reality. Am J Psychiatry. 2019;176(10):794–810.
Davison J, O’Gorman A, Brennan L, Cotter DR. A systematic review of metabolite biomarkers of schizophrenia. Schizophr Res. 2018;195:32–50.
Orešič M, Tang J, Seppänen-Laakso T, Mattila I, Saarni SE, Saarni SI, et al. Metabolome in schizophrenia and other psychotic disorders: a general population-based study. Genome Med. 2011;3(3):19.
Article PubMed PubMed Central Google Scholar
Bowden J, Holmes MV. Meta-analysis and mendelian randomization: a review. Res Synth Methods. 2019;10(4):486–96.
Article PubMed PubMed Central Google Scholar
Boehm FJ, Zhou X. Statistical methods for mendelian randomization in genome-wide association studies: a review. Comput Struct Biotechnol J. 2022;20:2338–51.
Article CAS PubMed PubMed Central Google Scholar
Wang C, Zhu D, Zhang D, Zuo X, Yao L, Liu T, et al. Causal role of immune cells in schizophrenia: mendelian randomization (MR) study. BMC Psychiatry. 2023;23(1):590.
Article PubMed PubMed Central Google Scholar
Jia Y, Hui L, Sun L, Guo D, Shi M, Zhang K, et al. Association between Human Blood Metabolome and the risk of Psychiatric disorders. Schizophr Bull. 2023;49(2):428–43.
Yang J, Yan B, Zhao B, Fan Y, He X, Yang L, et al. Assessing the Causal effects of human serum metabolites on 5 Major Psychiatric disorders. Schizophr Bull. 2020;46(4):804–13.
Article PubMed PubMed Central Google Scholar
Chen Y, Lu T, Pettersson-Kymmer U, Stewart ID, Butler-Laporte G, Nakanishi T, et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. 2023;55(1):44–53.
Article PubMed PubMed Central Google Scholar
Long T, Hicks M, Yu H-C, Biggs WH, Kirkness EF, Menni C, et al. Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites. Nat Genet. 2017;49(4):568–78.
Article CAS PubMed Google Scholar
Lotta LA, Pietzner M, Stewart ID, Wittemans LBL, Li C, Bonelli R, et al. A cross-platform approach identifies genetic regulators of human metabolism and health. Nat Genet. 2021;53(1):54–64.
Article CAS PubMed PubMed Central Google Scholar
Shin S-Y, Fauman EB, Petersen A-K, Krumsiek J, Santos R, Huang J, et al. An atlas of genetic influences on human blood metabolites. Nat Genet. 2014;46(6):543–50.
Article CAS PubMed PubMed Central Google Scholar
Yin X, Chan LS, Bose D, Jackson AU, VandeHaar P, Locke AE, et al. Genome-wide association studies of metabolites in Finnish men identify disease-relevant loci. Nat Commun. 2022;13(1):1644.
Article CAS PubMed PubMed Central Google Scholar
Hysi PG, Mangino M, Christofidou P, Falchi M, Karoly ED, Investigators NB, et al. Metabolome Genome-Wide Association Study identifies 74 novel genomic regions influencing plasma metabolites levels. Metabolites. 2022;12(1):61.
Article CAS PubMed PubMed Central Google Scholar
Dong T, Wang X, Jia Z, Yang J, Liu Y. Assessing the associations of 1,400 blood metabolites with major depressive disorder: a mendelian randomization study. Front Psychiatry. 2024;15:1391535.
Article PubMed PubMed Central Google Scholar
Li Q, Wei Z, Zhang Y, Zheng C. Causal role of metabolites in non-small cell lung cancer: mendelian randomization (MR) study. PLoS ONE. 2024;19(3):e0300904.
Article CAS PubMed PubMed Central Google Scholar
Ling K, Hong M, Jin L, Wang J. Blood metabolomic and postpartum depression: a mendelian randomization study. BMC Pregnancy Childbirth. 2024;24(1):429.
Article PubMed PubMed Central Google Scholar
Tang W, Jiang H, Wu X, Wu G, Zhao C, Lin W, et al. Metabolomic insights into pulmonary fibrosis: a mendelian randomization study. BMC Pulm Med. 2024;24(1):271.
Article PubMed PubMed Central Google Scholar
Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.
Article PubMed PubMed Central Google Scholar
Maciejewski ML, Dowd BE, Norton EC. Instrumental variables and Heterogeneous Treatment effects. JAMA. 2022;327(12):1177–8.
Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604(7906):502–8.
Article CAS PubMed PubMed Central Google Scholar
Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985–98.
Article PubMed PubMed Central Google Scholar
Gkatzionis A, Burgess S, Newcombe PJ. Statistical methods for cis-mendelian randomization with two-sample summary-level data. Genet Epidemiol. 2023;47(1):3–25.
Article CAS PubMed Google Scholar
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–14.
Article PubMed PubMed Central Google Scholar
Rodrigues-Amorim D, Rivera-Baltanás T, López M, Spuch C, Olivares JM, Agís-Balboa RC. Schizophrenia: a review of potential biomarkers. J Psychiatr Res. 2017;93:37–49.
Dang X, Song M, Lv L, Yang Y, Luo X-J. Proteome-wide mendelian randomization reveals the causal effects of immune-related plasma proteins on psychiatric disorders. Hum Genet. 2023;142(6):809–18.
留言 (0)